查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844408

生物影像市場按技術、產品、模式、應用和最終用戶分類－2025-2032年全球預測

Bio-imaging Market by Technology, Product, Modality, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物成像市場規模將成長 149 億美元，複合年成長率為 10.50%。

主要市場統計數據
基準年 2024 67億美元
預計年份：2025年 73.8億美元
預測年份：2032年 149億美元
複合年成長率 (%) 10.50%

本書清晰權威地闡述了成像技術、分析技術和臨床工作流程的整合如何重塑診斷準確性和研究管道。

生物影像領域正經歷重大變革，硬體、軟體和臨床整合的同步進步推動著這項變革。曾經各自獨立應用於診斷和手術的影像方式逐漸融合，形成以診斷準確性、工作流程效率和資料互通性為優先的混合工作流程。臨床醫生和研究人員都越來越重視影像衍生分析、縱向資料擷取和可重複的影像通訊協定，以支持個人化醫療和轉化研究。

在此背景下，對影像分析軟體、雲端原生資料管理和設備互通性的投資正在改變終端用戶的採購重點。這些轉變並非僅僅是技術層面的；它們反映了臨床管道的變化，即影像技術更緊密地融入治療決策和藥物研發流程。因此，製造商和解決方案提供者必須調整其創新策略，以適應不斷變化的臨床醫生需求、監管預期以及支付方對臨床價值的論證主導。本文的概要將闡述上述執行摘要，並為深入探討市場動態、政策影響、細分市場細微差別、區域差異以及為引領這一快速發展行業的領導者提供的建議行動奠定基礎。

人工智慧整合、模態混合、雲端協作和流程分散化如何重新定義生物成像的臨床工作流程和商業化模式

影像產業正經歷一場變革性的轉變，這場轉變不僅體現在產品的漸進式改進上，也體現在影像操作、分析和報銷方式的系統性變革上。人工智慧和機器學習已從概念驗證模型發展成為嵌入式工具，能夠增強放射科醫生的工作流程，自動化常規影像處理任務，並挖掘具有臨床意義的生物標記。因此，模型檢驗、監管核准管道以及如何將人工智慧輸出整合到臨床決策支援系統中的策略，正日益受到關注。

同時，越來越多的影像模式融合——例如內視鏡結合超音波結合造影造影和人工智慧解讀——正在拓展整個專科的臨床效用。雲端基礎的資料管理和安全的聯邦學習方法正在推動多中心協作，而邊緣運算則促進了在患者附近進行照護現場診斷的推理。儀器小型化和手術顯微鏡的進步正在將手術從住院轉移到門診病人和流動診療環境中，從而改變採購週期和資本規劃。所有這些轉變共同要求相關人員採用靈活的商業化模式，投資於監管和循證能力建設，並建立連接硬體、軟體和臨床服務的夥伴關係。

評估2025年貿易政策變化對供應鏈韌性、區域製造策略以及各相關人員採購決策的策略影響

2025年的關稅政策為全球成像硬體、組件和耗材的供應鏈和採購決策帶來了新的複雜性。更高的進口關稅和貿易政策調整可能會增加依賴國際採購零件的系統的到岸成本，從而增加製造商重新評估其供應商佈局和製造地的壓力。為此，許多公司正在加快供應商多元化進程，並尋找合格的替代組件來源，以維持生產的連續性和利潤率。

關稅不僅直接影響成本，還會影響企業在在地化、庫存策略以及與客戶的價格透明度等方面的策略選擇。一些供應商正在評估區域組裝和生產線末端製造方案，以減輕關稅的影響；而另一些供應商則在協商長期供應商協議，以確保優先獲得受限零件。此外，隨著企業尋求最佳化關稅待遇並利用貿易便利化機制，監管合規和關稅分類變得癒合重要。隨著企業適應日益細分且對政策更加敏感的貿易環境，它們正在重新調整採購計劃、資本配置和夥伴關係策略。

將機會與特定模式的創新、產品組合、應用需求和最終用戶購買行為聯繫起來的策略性細分洞察

細分分析揭示了技術、產品、模式、應用和最終用戶等維度上的創新與機會的交會點。在技​​術方面，磁振造影和X光成像等成熟模式仍是診斷的核心，而內視鏡、核子醫學影像、手術顯微鏡和超音波則隨著解析度、便攜性和整合性的提升，不斷拓展其臨床應用範圍。這種技術多樣性要求供應商根據特定模式的臨床工作流程和報銷動態，量身訂做提案主張。

產品細分錶明，儘管成像系統和儀器仍然是資本支出決策的核心，但試劑和軟體作為經常性收入的促進因素和差異化臨床結果的實現者，其重要性日益凸顯。在設備方面，CT掃描儀、 核磁共振造影系統和超音波設備具有不同的採購週期和服務模式，這會影響整體擁有成本的計算。軟體大致可分為兩類：一類是解決互通性和安全性問題的資料管理平台，另一類是提供分析洞察的影像分析工具。這兩類軟體在供應商差異化中扮演越來越重要的角色。2D和3D成像模式之間的差異凸顯了影像擷取、儲存和解讀方面的不同需求，尤其是在臨床診斷、藥物研發、研究和治療領域。最終用戶，例如門診手術中心、影像中心以及醫院和診所，對吞吐量、資本支出和電子健康記錄整合等方面的優先順序各不相同，這影響著他們的採購標準和售後服務期望。透過臨床工作流程和採購行為來解讀產品細分，可以幫助企業更好地將產品藍圖和商業模式與特定的需求促進因素相匹配。

美洲、歐洲、中東和非洲以及亞太地區的策略動態和差異化應用模式將體現在量身訂製的商業化和監管策略中。

區域動態將顯著影響美洲、歐洲、中東和非洲以及亞太地區的採用模式、監管路徑和商業性策略。在美洲，受醫院整合以及對門診病人和流動醫療設施投資增加的推動，醫療系統對先進診斷能力和軟體驅動的主導提升表現出強烈的需求。在這種環境下，能夠展現臨床效果和營運成本節約的整合解決方案更受青睞，而報銷動態和監管考量將決定採用速度。

中東和非洲市場的監管環境、國家醫療保健重點和基礎設施的差異正在影響打入市場策略。一些市場強調集中式、高品質的影像中心和國家篩檢項目，從而推動了對可擴展、可互通解決方案的需求。另一些市場則投資於擴大和現代化生產能力，為模組化系統和遠端服務交付創造了機會。亞太地區的特點是診斷基礎設施的快速擴張、對本地製造的投資以及對具成本效益高性能技術的重視。私人醫療保健的成長和旨在改善診斷可及性的公共舉措正在推動對高階和可攜式即時檢測（POC​​）設備的需求。成功的商業化需要在地化的服務網路、遵守區域監管框架以及進行符合文化背景的臨床檢驗。了解這些區域差異將有助於有針對性地分配資源和選擇夥伴關係，從​​而加速市場滲透。

競爭與合作的趨勢揭示了現有企業、創新者和軟體專家如何透過夥伴關係、併購和證據生成等方式攜手合作，在生物成像領域取得成功。

生物成像領域的競爭格局由傳統跨國供應商、敏捷的設備創新者和軟體專家組成。傳統製造商擁有規模優勢、龐大的用戶裝置量的服務網路以及豐富的監管經驗，這些優勢支撐著大額資本銷售和長期服務協議。同時，規模較小的公司和新興企業正在影像分析、雲端原生資料管理和照護現場設備等領域迅速推出顛覆性功能，促使它們透過夥伴關係、授權協議和有針對性的收購來加速自身能力建設。

隨著硬體供應商尋求將能夠展現可衡量的臨床價值的分析和資訊服務捆綁銷售，設備原始設備製造商 (OEM) 與軟體公司之間的策略合作日益普遍。與學術醫療中心和臨床研究機構建立合作關係對於證據產生和監管申報也至關重要。此外，投資於完善的上市後監測、網路安全保障和互通性標準的公司，在與需要安全且審核資料流的醫療保健系統競爭時，將佔據有利地位。在競爭激烈的市場環境中，能夠制定整合臨床檢驗、監管策略和市場進入靈活性的商業化計劃的公司將獲得豐厚的回報。

為領導者提供切實可行的策略指導，以加強供應鏈韌性，加速採用檢驗的人工智慧技術，並使模組化商業化與當地市場實際情況相符。

產業領導者應採取一系列協調一致的行動，將技術前景轉化為永續的商業性優勢。首先，實現供應鏈多元化，並對跨區域的製造合作夥伴進行認證，以降低貿易政策波動和關鍵零件短缺的風險。其次，優先發展模組化產品設計和服務，以實現更快的升級、更便利的維護和多樣化的資金籌措模式，從而滿足門診、診斷中心和醫院的採購偏好。第三，加快對檢驗的人工智慧和分析技術的投資，並專注於可解釋性、臨床檢驗和監管合規性，以建立臨床醫生的信任和支付方的認可。

同時，我們將加強與軟體供應商、學術中心和專科服務供應商的策略夥伴關係，共同開發將影像輸出與改善患者預後聯繫起來的證據。我們將實施健全的資料管治、網路安全和互通性框架，以促進多機構合作並確保雲端技術的安全應用。最後，我們將根據當地市場實際情況調整商業化計劃，使產品組合、服務模式和報銷策略與當地市場實際情況相符。這些措施將有助於我們降低執行風險，加快產品推廣速度，並在競爭激烈的市場環境中脫穎而出。

嚴謹的多方法研究設計，結合了初步訪談、二手證據綜合和迭代檢驗，確保為相關人員提供可靠且可操作的見解。

本研究綜合運用了定性和定量相結合的多方法研究途徑成果。主要研究包括對臨床負責人、採購負責人、技術主管和監管專家進行結構化訪談和情境研討會，以揭示痛點、推動技術應用和商業性優先事項。次要研究則包括對同儕審查文獻、監管申報文件、臨床指南和技術白皮書進行系統性回顧，以識別技術趨勢和證據要求。

資料三角測量法用於整合不同資訊來源的見解，主題分析則突顯了推廣過程中反覆出現的障礙和促進因素。與外部專家的驗證以及迭代回饋機制確保了結論能夠反映相關人員在實際工作中遇到的情況。檢驗調查方法和資料來源的嚴謹性透過對資料來源、訪談框架和假設檢驗的透明記錄得以保證，從而確保了研究結果的可重複性和研究建議的可靠性。在主要研究過程中，我們遵循了倫理考量和保密通訊協定，以保護參與者共用的專有資訊。

本文簡要概述了整合技術、檢驗的證據和本地化策略將如何決定生物影像技術在變革臨床護理和研究中的價值惠及對象。

摘要：生物成像正處於曲折點，日益精進的技術必須與務實的商業化策略相輔相成。先進影像技術、人工智慧賦能的分析以及雲端原生資料架構的融合，在釋放新的臨床能力的同時，也提高了人們對證據、互通性和資料管理的期望。監管的複雜性和地緣政治貿易動態，增加了策略考量，迫使企業調整供應鏈、加速臨床檢驗並完善商業模式。

決策者若能果斷行動，整合經過檢驗的軟體、模組化硬體和在地化客製化的服務模式，將最有利於創造價值。同樣重要的是，他們能夠證明可衡量的臨床和經濟影響。透過將創新藍圖與臨床醫生的工作流程、支付方的優先事項和當地監管環境相協調，相關人員可以將技術進步轉化為可擴展的臨床解決方案，從而改善治療效果並提高營運效率。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧演算法整合到高通量生物成像工作流程中
  • 多模態PET/MRI成像平台的興起，實現了全面的分子診斷
  • 用於即時活細胞成像應用的超高解析度顯微鏡技術的進步
  • 推出雲端基礎的生物成像資料管理解決方案，以實現可擴展的研究協作
  • 促進無標定光學成像技術的發展，以增強快速組織特性分析工作流程
  • 開發用於同步影像和標靶藥物傳遞的診療一體化造影造影
  • 將高解析度螢光顯微鏡與微流體實驗室晶片系統整合
  • 採用數位病理學和全切片成像技術可加快癌症診斷和分析速度。

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依技術分類的生物影像市場

  • 內視鏡檢查
  • 磁振造影
  • 核子造影
  • 手術顯微鏡
  • 超音波
  • X光影像

第9章 生物影像產品市場

  • 影像系統
  • 裝置
    • CT掃描儀
    • 核磁共振造影系統
    • 超音波設備
  • 試劑
  • 軟體
    • 資料管理軟體
    • 影像分析軟體

第10章 生物影像市場依影像方式分類

  • 2D成像
  • 3D成像

第11章 生物造影市場按應用領域分類

  • 臨床診斷
  • 藥物發現
  • 研究
  • 治療

第12章 生物成像市場（依最終用戶分類）

  • 門診手術中心
  • 診斷影像中心
  • 醫院和診所

第13章 生物影像市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 生物影像市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國生物影像市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • BaySpec, Inc.
    • Bracco SpA
    • Bruker Corporation
    • Canon Medical Systems Corporation
    • Digirad Corporation
    • Esaote SpA
    • Fujifilm Holdings Corporation
    • GE HealthCare Technologies, Inc.
    • Hitachi Medical Corporation
    • HT BioImaging Ltd
    • iThera Medical GmbH
    • Kitware, Inc.
    • Koninklijke Philips NV
    • Lantheus Medical Imaging, Inc.
    • M Squared Lasers Ltd.
    • MARS Bioimaging Limited
    • Medtronic PLC
    • MobileODT Ltd by Liger Medical LLC
    • Perspectum Ltd.
    • Quibim, SL
    • RadNet, Inc.
    • Rivanna Medical, Inc.
    • Samsung Medison Co., Ltd.
    • Siemens Healthineers
Product Code: MRR-710B1F0AC3D1

The Bio-imaging Market is projected to grow by USD 14.90 billion at a CAGR of 10.50% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.70 billion
Estimated Year [2025] USD 7.38 billion
Forecast Year [2032] USD 14.90 billion
CAGR (%) 10.50%

A clear and authoritative framing of how convergent imaging technologies, analytics, and clinical workflows are reshaping diagnostic precision and research pathways

The bio-imaging landscape is undergoing a profound evolution driven by parallel advances in hardware, software, and clinical integration. Imaging modalities that were once siloed within diagnostic or surgical contexts are converging into hybrid workflows that prioritize diagnostic precision, workflow efficiency, and data interoperability. Clinicians and researchers alike are placing greater emphasis on image-derived analytics, longitudinal data capture, and reproducible imaging protocols to support personalized care and translational research.

Against this backdrop, investments in image analysis software, cloud-native data management, and device interoperability are reshaping procurement priorities across end users. These shifts are not merely technological; they reflect changing clinical pathways that integrate imaging more tightly into therapeutic decision-making and drug development pipelines. As a result, manufacturers and solution providers must align innovation strategies with evolving clinician needs, regulatory expectations, and payer-driven demands for demonstrable clinical value. This introduction frames the executive summary that follows, setting the stage for detailed discussion of market dynamics, policy impacts, segmentation nuances, regional variations, and recommended actions for leaders navigating this fast-evolving sector.

How AI integration, modality hybridization, cloud-enabled collaboration, and procedural decentralization are jointly redefining clinical workflows and commercialization models in bio-imaging

The industry is experiencing transformative shifts that extend beyond incremental product improvements to systemic changes in how imaging is performed, analyzed, and reimbursed. Artificial intelligence and machine learning have matured from proof-of-concept models into embedded tools that augment radiologist workflows, automate routine image processing tasks, and surface clinically actionable biomarkers. Consequently, attention has turned to model validation, regulatory approval pathways, and strategies to integrate AI outputs into clinical decision support systems.

Simultaneously, hybridization of modalities-where endoscopy is combined with high-resolution imaging, or ultrasound is augmented by contrast agents and AI interpretation-has expanded clinical utility across specialties. Cloud-based data management and secure federated learning approaches are enabling multi-institutional collaboration, while edge computing is facilitating near-patient inference for point-of-care diagnostics. Device miniaturization and advances in surgical microscopy are shifting procedures from inpatient to ambulatory and outpatient settings, altering purchasing cycles and capital planning. Collectively, these shifts demand that stakeholders adopt flexible commercialization models, invest in regulatory and evidence generation capabilities, and form partnerships that bridge hardware, software, and clinical services.

Assessing the strategic implications of 2025 trade policy changes on supply chain resilience, regional manufacturing strategies, and procurement decision-making across imaging stakeholders

The tariff landscape of 2025 has introduced new complexities into global supply chains and procurement decisions for imaging hardware, components, and consumables. Increased import duties and trade policy adjustments have the potential to raise landed costs for systems that rely on internationally sourced components, intensifying pressure on manufacturers to reassess supplier footprints and manufacturing locations. In response, many firms are accelerating supplier diversification and qualifying alternate component sources to sustain production continuity and preserve margin integrity.

Beyond direct cost implications, tariffs influence strategic choices about localization, inventory strategies, and pricing transparency with customers. Some vendors are evaluating regional assembly or final-stage manufacturing to mitigate tariff exposure while others are negotiating long-term supplier agreements to secure priority access to constrained components. Additionally, regulatory compliance and customs classification have become more prominent as companies seek to optimize tariff treatments and leverage trade facilitation mechanisms. The aggregate effect is a recalibration of procurement timelines, capital allocation, and partnership strategies as organizations adapt to a more fragmented and policy-sensitive trade environment.

Strategic segmentation insights that connect modality-specific innovation, product composition, application needs, and end-user procurement behavior to commercial opportunity

Segmentation analysis illuminates where innovation and commercial opportunity intersect across technology, product, modality, application, and end-user dimensions. When considering technology, mature modalities such as magnetic resonance imaging and X-ray imaging continue to be core diagnostic pillars, while endoscopy, nuclear imaging, surgical microscopy, and ultrasound are expanding their clinical reach through enhancements in resolution, portability, and integration. This technological diversity requires vendors to tailor value propositions that align with modality-specific clinical workflows and reimbursement dynamics.

Product segmentation reveals that imaging systems and instruments remain central to capital investment decisions, yet reagents and software are increasingly important as recurring revenue drivers and enablers of differentiated clinical outcomes. Within instruments, CT scanners, MRI machines, and ultrasound devices have distinct procurement cycles and service models that influence total cost of ownership conversations. Software divides broadly into data management platforms that address interoperability and security, and image analysis tools that deliver analytic insights; both categories play a growing role in vendor differentiation. Modality distinctions between 2D and 3D imaging underscore divergent requirements for image acquisition, storage, and interpretation, particularly in applications spanning clinical diagnostics, drug discovery, research, and therapeutics. End users such as ambulatory surgical centers, diagnostic imaging centers, and hospitals and clinics each prioritize different combinations of throughput, capital expense, and integration with electronic health records, shaping purchase criteria and post-sale service expectations. By interpreting segmentation through the lens of clinical workflows and purchasing behavior, organizations can better align product road maps and commercial models to specific demand drivers.

Regional strategic dynamics and differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform tailored commercialization and regulatory approaches

Regional dynamics materially influence adoption patterns, regulatory pathways, and commercial approaches across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, healthcare systems exhibit a strong appetite for advanced diagnostic capabilities and software-driven efficiency gains, supported by consolidated hospital networks and growing investment in outpatient and ambulatory care sites. This environment favors integrated solutions that demonstrate clinical impact and operational savings, while reimbursement dynamics and regulatory considerations guide the pace of adoption.

Europe Middle East & Africa presents a heterogeneous landscape where regulatory stringency, national health priorities, and infrastructure variability shape market entry strategies. Some markets emphasize centralized, high-quality imaging centers and national screening programs, prompting demand for scalable, interoperable solutions. Other markets are investing in capacity expansion and modernization, creating opportunities for modular systems and remote service offerings. Asia-Pacific is characterized by rapid expansion of diagnostic infrastructure, investments in local manufacturing, and strong interest in cost-effective, high-throughput technologies. Private healthcare growth and public initiatives to improve access to diagnostics are driving demand for both high-end modalities and portable point-of-care devices. Across regions, localization of service networks, compliance with regional regulatory frameworks, and culturally informed clinical validation are essential for successful commercialization. Understanding these regional distinctions enables targeted resource allocation and partnership selection to accelerate market penetration.

Competitive and collaborative company trends that reveal how incumbents, innovators, and software specialists are aligning through partnerships, M&A, and evidence generation to win in bio-imaging

Competitive dynamics in bio-imaging are shaped by a mix of legacy multinationals, nimble device innovators, and specialist software vendors. Legacy manufacturers retain strengths in scale, installed base service networks, and regulatory experience, which support large capital sales and long-term service agreements. At the same time, smaller firms and startups are rapidly introducing disruptive capabilities in image analysis, cloud-native data management, and point-of-care devices, prompting partnerships, licensing agreements, and targeted acquisitions to accelerate capability build-out.

Strategic collaborations between device OEMs and software companies are becoming more commonplace as hardware vendors seek to bundle analytic and data services that demonstrate measurable clinical value. Partnerships with academic medical centers and clinical research organizations are also essential for evidence generation and regulatory submissions. Moreover, companies that invest in robust post-market surveillance, cyber-security safeguards, and interoperability standards position themselves favorably with health systems that require secure, auditable data flows. The competitive landscape rewards firms that can integrate clinical validation, regulatory strategy, and go-to-market agility into a cohesive commercialization plan.

Actionable strategic guidance for leaders to enhance supply chain resilience, accelerate validated AI adoption, and align modular commercialization with regional market realities

Industry leaders should pursue a set of coordinated actions to translate technological promise into sustainable commercial advantage. First, diversify supply chains and qualify multi-regional manufacturing partners to reduce exposure to trade policy volatility and critical component shortages. Second, prioritize modular product design and services that enable faster upgrades, easier maintenance, and varied financing models adapted to ambulatory, diagnostic center, and hospital procurement preferences. Third, accelerate investment in validated AI and analytics, focusing on explainability, clinical validation, and regulatory alignment to build clinician trust and payer acceptance.

In parallel, strengthen strategic partnerships with software vendors, academic centers, and specialty service providers to co-develop evidence that links imaging outputs to improved patient outcomes. Implement robust data governance, cybersecurity, and interoperability frameworks to facilitate multi-institutional collaboration and secure cloud deployments. Finally, align commercialization plans with regional nuances by tailoring product configurations, service models, and reimbursement strategies to local market realities. These actions collectively reduce execution risk, increase adoption velocity, and create defensible differentiation in a competitive landscape.

Rigorous multi-method research design combining primary interviews, secondary evidence synthesis, and iterative validation to ensure robust, actionable insights for stakeholders

The study synthesizes insights from a multi-method research approach combining qualitative and quantitative techniques. Primary research consisted of structured interviews and scenario workshops with clinical leaders, procurement officers, technology executives, and regulatory specialists to surface pain points, adoption drivers, and commercial priorities. Secondary research involved a systematic review of peer-reviewed literature, regulatory filings, clinical guidelines, and technical whitepapers to contextualize technological trends and evidence requirements.

Data triangulation was used to reconcile insights across sources, while thematic analysis highlighted recurring adoption barriers and success factors. Validation exercises with external experts and iterative feedback loops ensured that conclusions reflect practical realities encountered by field stakeholders. Methodological rigor was maintained through transparent documentation of data sources, interview frameworks, and assumption checks, enabling reproducibility and confidence in the study's recommendations. Ethical considerations and confidentiality protocols were observed during primary engagements to protect proprietary information shared by participants.

Concise synthesis of how integrated technology, validated evidence, and regionally informed strategy will determine who captures value as bio-imaging transforms clinical care and research

In summary, bio-imaging stands at an inflection point where technological sophistication must be matched by pragmatic commercialization strategies. The convergence of advanced modalities, AI-enabled analytics, and cloud-native data architectures is unlocking new clinical capabilities while simultaneously raising expectations for evidence, interoperability, and data stewardship. Regulatory complexity and geopolitical trade dynamics add layers of strategic consideration, compelling organizations to adapt supply chains, accelerate clinical validation, and refine commercial models.

Decision-makers who act decisively to integrate validated software, modular hardware, and regionally attuned service models will be best positioned to capture value. Equally important is the ability to demonstrate measurable clinical and economic impact, which increasingly governs adoption and reimbursement. By aligning innovation road maps with clinician workflows, payer priorities, and regional regulatory contexts, stakeholders can convert technical advances into scalable clinical solutions that improve outcomes and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence powered algorithms in high throughput bio imaging workflows
  • 5.2. Rise of multimodal PET MRI imaging platforms enabling comprehensive molecular diagnostics
  • 5.3. Advancement of super resolution microscopy techniques for real time live cell imaging applications
  • 5.4. Emergence of cloud based bio imaging data management solutions for scalable research collaboration
  • 5.5. Growth of label free optical imaging modalities enhancing rapid tissue characterization workflows
  • 5.6. Development of theranostic contrast agents for simultaneous imaging and targeted drug delivery
  • 5.7. Integration of microfluidic lab on a chip systems with high resolution fluorescence microscopy
  • 5.8. Adoption of digital pathology and whole slide imaging for accelerated cancer diagnostics and analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bio-imaging Market, by Technology

  • 8.1. Endoscopy
  • 8.2. Magnetic Resonance Imaging
  • 8.3. Nuclear Imaging
  • 8.4. Surgical Microscopy
  • 8.5. Ultrasound
  • 8.6. X-ray Imaging

9. Bio-imaging Market, by Product

  • 9.1. Imaging Systems
  • 9.2. Instruments
    • 9.2.1. CT Scanners
    • 9.2.2. MRI Machines
    • 9.2.3. Ultrasound Devices
  • 9.3. Reagents
  • 9.4. Software
    • 9.4.1. Data Management Software
    • 9.4.2. Image Analysis Software

10. Bio-imaging Market, by Modality

  • 10.1. 2D Imaging
  • 10.2. 3D Imaging

11. Bio-imaging Market, by Application

  • 11.1. Clinical Diagnostics
  • 11.2. Drug Discovery
  • 11.3. Research
  • 11.4. Therapeutics

12. Bio-imaging Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Diagnostic Imaging Centers
  • 12.3. Hospitals & Clinics

13. Bio-imaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bio-imaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bio-imaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. BaySpec, Inc.
    • 16.3.2. Bracco S.p.A.
    • 16.3.3. Bruker Corporation
    • 16.3.4. Canon Medical Systems Corporation
    • 16.3.5. Digirad Corporation
    • 16.3.6. Esaote S.p.A
    • 16.3.7. Fujifilm Holdings Corporation
    • 16.3.8. GE HealthCare Technologies, Inc.
    • 16.3.9. Hitachi Medical Corporation
    • 16.3.10. HT BioImaging Ltd
    • 16.3.11. iThera Medical GmbH
    • 16.3.12. Kitware, Inc.
    • 16.3.13. Koninklijke Philips N.V.
    • 16.3.14. Lantheus Medical Imaging, Inc.
    • 16.3.15. M Squared Lasers Ltd.
    • 16.3.16. MARS Bioimaging Limited
    • 16.3.17. Medtronic PLC
    • 16.3.18. MobileODT Ltd by Liger Medical LLC
    • 16.3.19. Perspectum Ltd.
    • 16.3.20. Quibim, S.L.
    • 16.3.21. RadNet, Inc.
    • 16.3.22. Rivanna Medical, Inc.
    • 16.3.23. Samsung Medison Co., Ltd.
    • 16.3.24. Siemens Healthineers

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BIO-IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BIO-IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIO-IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIO-IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS BIO-IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BIO-IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL BIO-IMAGING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL BIO-IMAGING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. GCC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. GCC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. GCC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. GCC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. GCC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 316. GCC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 317. GCC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 318. GCC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 319. GCC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 320. GCC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 321. GCC BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 322. GCC BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 323. GCC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. GCC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. GCC BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. GCC BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 335. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 336. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 340. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 341. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. BRICS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 344. BRICS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 345. BRICS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 346. BRICS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 347. BRICS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 348. BRICS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 349. BRICS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 350. BRICS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 351. BRICS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 352. BRICS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 353. BRICS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 354. BRICS BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 355. BRICS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 356. BRICS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 357. BRICS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 358. BRICS BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 359. G7 BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 360. G7 BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 361. G7 BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 362. G7 BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 363. G7 BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 364. G7 BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 365. G7 BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 366. G7 BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 367. G7 BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD